Myomo MYO
NYSE MYO
$1.73 -0.01 (-0.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

Myomo (MYO) Non-Current Deferred Tax Liability (2024)

Myomo's (MYO) quarterly Non-Current Deferred Tax Liability came in at $1.9 million in Q4 2024.

Myomo (MYO) Non-Current Deferred Tax Liability (2024) Analysis & Trends

Myomo (MYO) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $1.9 million in Q4 2024.

  • Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $1.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.9 million (changed N/A YoY) and the FY2024 annual result came in at $1.9 million, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability steadied at $1.9 million in Q4 2024.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.9 million in Q4 2024 to a low of $1.9 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Myomo 67.26 Mn 48.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 1.87 Mn
Dec 31, 2024 1.87 Mn